Literature DB >> 19429865

Abundant c-Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death.

Yu Yu1, Cristina Iclozan, Tomohide Yamazaki, Xuexian Yang, Claudio Anasetti, Chen Dong, Xue-Zhong Yu.   

Abstract

Activation-induced cell death (AICD) plays an important role in peripheral T-cell tolerance. AICD in CD4 T helper (Th) cells, including Th1 and Th2 effectors, has been extensively studied. Recently, interleukin-17-producing CD4(+) T cells (Th17 cells) have been identified as a unique Th subset, but their susceptibility to AICD and the underlying molecular mechanisms have not been defined. In this study, we found that Th17 cells were significantly less susceptible to AICD than Th1 cells, and Th17 cell resistance to AICD is due to the high levels of c-Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein preventing Fas-mediated apoptosis. The resistance of Th17 cells to AICD reveals a novel mechanism to explain the high pathogenicity of Th17 cells in autoimmune diseases, and may also provide a rationale to generate tumor-specific Th17 cells for adoptive immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429865      PMCID: PMC2721783          DOI: 10.1182/blood-2009-03-210153

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex.

Authors:  A Krueger; I Schmitz; S Baumann; P H Krammer; S Kirchhoff
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

2.  Modulation of cell death by Bcl-XL through caspase interaction.

Authors:  R J Clem; E H Cheng; C L Karp; D G Kirsch; K Ueno; A Takahashi; M B Kastan; D E Griffin; W C Earnshaw; M A Veliuona; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

3.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

Review 4.  Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes.

Authors:  D Kabelitz; T Pohl; K Pechhold
Journal:  Immunol Today       Date:  1993-07

5.  TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity.

Authors:  S Kirchhoff; W W Müller; A Krueger; I Schmitz; P H Krammer
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.

Authors:  K Kovalovich; W Li; R DeAngelis; L E Greenbaum; G Ciliberto; R Taub
Journal:  J Biol Chem       Date:  2001-05-10       Impact factor: 5.157

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

Review 8.  The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

Authors:  Arthur I Roberts; Satish Devadas; Xiaoren Zhang; Liying Zhang; Achsah Keegan; Kristy Greeneltch; Jennifer Solomon; Lixin Wei; Jyoti Das; Erwei Sun; Catherine Liu; Zengrong Yuan; Jian-Nian Zhou; Yufang Shi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis.

Authors:  X Zhang; T Brunner; L Carter; R W Dutton; P Rogers; L Bradley; T Sato; J C Reed; D Green; S L Swain
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

10.  CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function.

Authors:  Pushpa Pandiyan; Dagmar Gärtner; Osman Soezeri; Andreas Radbruch; Klaus Schulze-Osthoff; Monika C Brunner-Weinzierl
Journal:  J Exp Med       Date:  2004-03-08       Impact factor: 14.307

View more
  24 in total

1.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Precarious balance: Th17 cells in host defense.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

3.  Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis.

Authors:  Yujiang Fang; Shiguang Yu; Jason S Ellis; Tumenjargal Sharav; Helen Braley-Mullen
Journal:  J Leukoc Biol       Date:  2010-06       Impact factor: 4.962

4.  Bim is required for T-cell allogeneic responses and graft-versus-host disease in vivo.

Authors:  Yu Yu; Jing Yu; Cristina Iclozan; Kane Kaosaard; Claudio Anasetti; Xue-Zhong Yu
Journal:  Am J Blood Res       Date:  2012-01-01

5.  Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis.

Authors:  Daniel J Neitzke; Jacob S Bowers; Kristina Andrijauskaite; Nathaniel S O'Connell; Elizabeth Garrett-Mayer; John Wrangle; Zihai Li; Chrystal M Paulos; David J Cole; Mark P Rubinstein
Journal:  Cancer Immunol Immunother       Date:  2017-03-09       Impact factor: 6.968

Review 6.  Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.

Authors:  Julia K Gittler; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2012-08-28       Impact factor: 10.793

Review 7.  When worlds collide: Th17 and Treg cells in cancer and autoimmunity.

Authors:  Hannah M Knochelmann; Connor J Dwyer; Stefanie R Bailey; Sierra M Amaya; Dirk M Elston; Joni M Mazza-McCrann; Chrystal M Paulos
Journal:  Cell Mol Immunol       Date:  2018-03-21       Impact factor: 11.530

8.  Inflammation-inducing Th1 and Th17 cells differ in their expression patterns of apoptosis-related molecules.

Authors:  Cuiyan Tan; Madhu Ramaswamy; Guangpu Shi; Barbara P Vistica; Richard M Siegel; Igal Gery
Journal:  Cell Immunol       Date:  2011-08-17       Impact factor: 4.868

9.  IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.

Authors:  Carlos A Arbelaez; Simon Glatigny; Rebekka Duhen; Gerard Eberl; Mohamed Oukka; Estelle Bettelli
Journal:  J Immunol       Date:  2015-07-29       Impact factor: 5.422

10.  Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion.

Authors:  Jacob S Bowers; Michelle H Nelson; Kinga Majchrzak; Stefanie R Bailey; Baerbel Rohrer; Andrew Dm Kaiser; Carl Atkinson; Luca Gattinoni; Chrystal M Paulos
Journal:  JCI Insight       Date:  2017-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.